Biosintex Srl of Snagov, Jud. Ilfov at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Biosintex Srl

Sos. Vladiceasca, Nr. 4, 077168 Snagov, Jud. Ilfov
Romania
Telephone +40 21 266 00 01
Fax +40 21 266 00 02
contact@biosintex.com

Hall map

MEDICA 2019 hall map (Hall 7): stand C01

Fairground map

MEDICA 2019 fairground map: Hall 7

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.05  Implants and protheses
  • 01.05.04  Other implants and protheses

Other implants and protheses

  • 05  Commodities and Consumer Goods
  • 05.01  Universal medical commodities

Universal medical commodities

  • 05  Commodities and Consumer Goods
  • 05.07  Disposables
  • 05.07.01  Disposable articles for hospitals

Disposable articles for hospitals

  • 05  Commodities and Consumer Goods
  • 05.07  Disposables
  • 05.07.03  Disposable articles for surgeries

Disposable articles for surgeries

Our products

Product category: Disposable articles for surgeries

BICRIL

Multifilament, synthetic, absorbable surgical suture, made of polyglycolic acid. These sutures are indicated for use, particularly, in general surgery, for the abdominal wall closure, for the intestinal anasthomosis, for ligations, or for the approximation of tissues requiring a wound support for 2 to 3 weeks. The thread is coated with polycaprolactone and calcium stearate. The coating reduces the tissue trauma and the risk of bacteria migration along the thread.

More Less

Product category: Disposable articles for surgeries

BICRIL 910

Multifilament, synthetic, absorbable surgical suture, composed of a copolymer made from 90% glycolide and 10% L-lactide. These sutures are indicated for use in soft tissue approximation and/or ligation, in ophthalmic procedures, ideal for any tissue requiring a wound support for 2 to 3 weeks. It is not indicated for use in cardiovascular and neurological tissues. Coated with a copolymer poly (glicolide-co-lactide) (30/70) and calcium stearate. The coating reduces the tissue trauma and the risk of bacteria migration along the thread.

More Less

Product category: Disposable articles for surgeries

BICRIL RAPID

Multifilament, synthetic, absorbable, sterile suture made of polyglycolic acid. Due to this rapid absorption property, BICRIL RAPID sutures are indicated for use to closing skin wounds, especially in pediatric surgery, episiotomies, circumcision and sutures of oral mucosa. Also, it is used in ophthalmic surgery for suture of connective tissues, but not for use in cardiovascular or neurological tissues. It is coated with calcium stearate and polycaprolactone, which reduces the capillary effect.

More Less

About us

Company details

BIOSINTEX was founded in 2002 by a family of doctors, with the aim of protecting people’s health and taking part in saving human lives. The surgeon who, through perseverance made this dream become reality, wanted to create innovative, qualitative medical devices, which ensure the safety and comfort of all types of surgical procedures, and rapid postoperative recovery of the patients.

BIOSINTEX is, currently, the only local manufacturer of surgical sutures and the domestic market leader, but also an important exporter in over more than 20 countries worldwide.

The company produces surgical sutures in a wide range of types and sizes, with or without needle, by using next-generation technology, high quality raw materials, certified by prestigious certification bodies. Our portfolio also includes surgical prosthesis for soft tissue and surgical meshes for urinary incontinence.

In our production unit there are over 100 dedicated employees which are daily committed to ensure excellence through the quality of our products. Our team devotes itself to a successful implementation of a quality control system by continuously testing the technical and quality parameters throughout the whole production flow.

The development of the R&D department and our wish to continuously evolve, in line with the progress of surgery, has led to the introduction of at least five new technologies over the past few years and to development of at least 100 new items in our portfolio. Our performance has constantly increased to meet the growing demands of our customers.

More Less